Description
Syna Peptides – CJC-1295 (No DAC) + Ipamorelin Blend is a research peptide combination designed to study growth hormone (GH) release through complementary signaling pathways.
This blend combines CJC-1295 without DAC, a GHRH analogue that supports the body’s natural pulsatile growth-hormone signaling, with Ipamorelin, a selective GHRP that acts on the ghrelin receptor (GHSR). Together, these peptides are used in research models to explore synergistic GH-related signaling through dual receptor activation.
The blend is produced under strict laboratory standards and verified using High-Performance Liquid Chromatography (HPLC) to ensure a purity of ≥99%. It is intended exclusively for controlled in-vitro endocrinological and biochemical research.
Blend Composition
-
CJC-1295 (No DAC) – 5 mg
Studied for its role in supporting natural, pulsatile growth-hormone release via the GHRH receptor. -
Ipamorelin – 5 mg
Researched for its selective activation of the ghrelin receptor (GHSR), without interaction with cortisol or prolactin pathways.
Product Details
-
Name: CJC-1295 (No DAC) + Ipamorelin Blend
-
Total Content: 10 mg (5 mg CJC-1295 No DAC + 5 mg Ipamorelin)
-
Type: Combination of GHRH and GHRP analogues
-
Form: Lyophilized (dry powder)
-
Purity: ≥99% (HPLC tested)
-
Storage: Store refrigerated, protected from light and moisture
Research Use Notice
For in-vitro laboratory research use only.
Not for human or animal use.
Not intended for medical or therapeutic application.



